- Home
- ALNY vs WMB Comparison
ALNY vs WMB Comparison
Compare ALNY & WMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- WMB
- Stock Information
- Founded
- ALNY 2002
- WMB 1908
- Country
- ALNY United States
- WMB United States
- Employees
- ALNY N/A
- WMB N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- WMB Natural Gas Distribution
- Sector
- ALNY Health Care
- WMB Utilities
- Exchange
- ALNY Nasdaq
- WMB Nasdaq
- Market Cap
- ALNY 59.6B
- WMB 69.7B
- IPO Year
- ALNY 2004
- WMB N/A
- Fundamental
- Price
- ALNY $450.56
- WMB $60.29
- Analyst Decision
- ALNY Strong Buy
- WMB Buy
- Analyst Count
- ALNY 29
- WMB 16
- Target Price
- ALNY $435.04
- WMB $60.67
- AVG Volume (30 Days)
- ALNY 1.1M
- WMB 5.6M
- Earning Date
- ALNY 10-30-2025
- WMB 11-05-2025
- Dividend Yield
- ALNY N/A
- WMB 3.39%
- EPS Growth
- ALNY N/A
- WMB N/A
- EPS
- ALNY N/A
- WMB 1.99
- Revenue
- ALNY $2,461,963,000.00
- WMB $11,363,000,000.00
- Revenue This Year
- ALNY $58.79
- WMB $10.55
- Revenue Next Year
- ALNY $39.75
- WMB $7.15
- P/E Ratio
- ALNY N/A
- WMB $29.68
- Revenue Growth
- ALNY 5.01
- WMB 10.83
- 52 Week Low
- ALNY $205.87
- WMB $44.51
- 52 Week High
- ALNY $484.21
- WMB $63.45
- Technical
- Relative Strength Index (RSI)
- ALNY 53.89
- WMB 63.56
- Support Level
- ALNY $454.51
- WMB $57.66
- Resistance Level
- ALNY $467.28
- WMB $59.35
- Average True Range (ATR)
- ALNY 12.99
- WMB 1.09
- MACD
- ALNY -4.42
- WMB 0.26
- Stochastic Oscillator
- ALNY 21.20
- WMB 98.36
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About WMB Williams Companies Inc. (The)
Williams Companies is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.